Duyac, Angelyn A.
HRN: 15-30-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/16/2024
08/22/2024
IV
500 Mg
Q8
Sp 1 LTCS Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes